Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2015-03-12 (11 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: QUEYRAC (33340), Gironde
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE QUEYRAC : revenue, balance sheet and financial ratios
PHARMACIE DE QUEYRAC is a French company
founded 11 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in QUEYRAC (33340),
this company of category PME
shows in 2025 a net income positive of 437 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE QUEYRAC (SIREN 810155317)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
436 704 €
336 816 €
285 086 €
346 682 €
289 294 €
219 341 €
214 413 €
206 388 €
183 968 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
En 2025, PHARMACIE DE QUEYRAC genera un resultado neto positivo de 437 k€. Evolución 2017-2025: 184 k€ -> 437 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
436 704 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
El ratio de endeudamiento (= Deuda financiera / Fondos propios x 100) se sitúa en 44%. La deuda permanece bajo control. La autonomía financiera (= Fondos propios / Total activo x 100) alcanza el 58%. Esta alta autonomía significa que la empresa financia la mayoría de sus activos con fondos propios.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
44.021%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
58.006%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE QUEYRAC
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
460.726
308.761
212.319
147.102
94.283
115.816
118.017
82.151
44.021
Financial autonomy
15.287
21.155
27.665
35.55
44.044
39.215
39.294
47.077
58.006
Repayment capacity
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Ratio de endeudamiento
44.022025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Bueno-16 pts over 3 years
En 2025, el ratio de endeudamiento de PHARMACIE DE QUEYRAC (44.02) se sitúa por debajo de la mediana del sector. Este ratio mide el peso de la deuda en relación con el patrimonio. Esta posición controlada refleja una gestión prudente.
Autonomía financiera
58.01%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Bueno+17 pts over 3 years
En 2025, el autonomía financiera de PHARMACIE DE QUEYRAC (58.0%) se sitúa por encima de la mediana del sector. Este ratio representa la parte del patrimonio en la financiación total. Esta posición cómoda ofrece un margen de seguridad apreciable.
Liquidity ratios
El ratio de liquidez se sitúa en 204.51. La empresa tiene 2€ de activos líquidos por cada 1€ de deuda a corto plazo.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
204.512
Liquidity indicators evolution PHARMACIE DE QUEYRAC
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
165.459
166.707
182.241
188.251
189.485
210.214
200.48
204.019
204.512
Interest coverage
None
None
None
None
None
None
None
None
None
Sector positioning
Ratio de liquidez
204.512025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Bueno
En 2025, el ratio de liquidez de PHARMACIE DE QUEYRAC (204.51) se sitúa por encima de la mediana del sector. Este ratio mide la capacidad de cubrir deuda a corto plazo con activos corrientes. Esta posición cómoda ofrece un margen de seguridad apreciable.
Positioning of PHARMACIE DE QUEYRAC in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DE QUEYRAC is estimated at
6 937 094 €
(range 4 707 545€ - 10 885 257€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
4707k€6937k€10885k€
6 937 094 €Range: 4 707 545€ - 10 885 257€
NAF 5 année 2025
Valuation method used
Net Income Multiple
436 704 €
×
15.9x
=6 937 095 €
Range: 4 707 545€ - 10 885 257€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE QUEYRAC with other companies in the same sector:
Frequently asked questions about PHARMACIE DE QUEYRAC
What is the revenue of PHARMACIE DE QUEYRAC ?
The revenue of PHARMACIE DE QUEYRAC is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DE QUEYRAC profitable?
Yes, PHARMACIE DE QUEYRAC generated a net profit of 437 k€ in 2025.
Where is the headquarters of PHARMACIE DE QUEYRAC ?
The headquarters of PHARMACIE DE QUEYRAC is located in QUEYRAC (33340), in the department Gironde.
Where to find the tax return of PHARMACIE DE QUEYRAC ?
The tax return of PHARMACIE DE QUEYRAC is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE QUEYRAC operate?
PHARMACIE DE QUEYRAC operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart